RIZZO, MICHELANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.784
EU - Europa 2.757
AS - Asia 1.875
SA - Sud America 297
AF - Africa 99
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.737
RU - Federazione Russa 1.033
SG - Singapore 606
IT - Italia 547
IE - Irlanda 341
CN - Cina 339
HK - Hong Kong 338
SE - Svezia 312
BR - Brasile 241
VN - Vietnam 194
KR - Corea 192
FI - Finlandia 109
FR - Francia 98
IN - India 80
GB - Regno Unito 75
DE - Germania 74
UA - Ucraina 74
AU - Australia 60
CI - Costa d'Avorio 47
CH - Svizzera 43
CA - Canada 27
JP - Giappone 23
NG - Nigeria 23
AR - Argentina 19
BD - Bangladesh 16
TR - Turchia 16
EC - Ecuador 15
IQ - Iraq 15
NL - Olanda 12
PL - Polonia 12
MA - Marocco 8
MX - Messico 8
PE - Perù 8
JO - Giordania 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
ES - Italia 6
BE - Belgio 5
CO - Colombia 5
JM - Giamaica 4
PH - Filippine 4
RO - Romania 4
SC - Seychelles 4
UZ - Uzbekistan 4
VE - Venezuela 4
BH - Bahrain 3
PY - Paraguay 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CD - Congo 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
ID - Indonesia 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
MU - Mauritius 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.874
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.762
Singapore 361
Dublin 341
Chandler 306
Hong Kong 255
Fairfield 232
Seoul 184
Ashburn 172
San Jose 144
Buffalo 131
Jacksonville 116
Woodbridge 109
Cambridge 108
Milan 95
Dallas 94
Seattle 94
Wilmington 88
Princeton 86
Beijing 83
Boston 83
Lauterbourg 78
The Dalles 72
Houston 66
Rome 66
Boardman 64
Melbourne 59
Ann Arbor 57
Ho Chi Minh City 52
Mumbai 50
Los Angeles 48
Abidjan 47
Bern 43
Hanoi 35
Hefei 35
Moscow 29
Florence 24
Medford 24
Redondo Beach 23
Shanghai 23
Tokyo 23
Abuja 22
New York 22
Falls Church 20
Munich 20
Naples 19
São Paulo 17
Orem 16
Palermo 16
Toronto 16
Turin 16
Helsinki 15
Kent 13
Andover 12
San Diego 12
Bologna 11
Da Nang 11
Frankfurt am Main 11
Manchester 11
Warsaw 11
Figino 10
Hillsboro 10
Lawrence 10
Norwalk 10
Amsterdam 9
Brooklyn 9
Haiphong 9
Chennai 8
Padua 8
Altamura 7
Bari 7
Izmir 7
Paris 7
Portsmouth 7
Rio de Janeiro 7
Tianjin 7
Turku 7
Verona 7
Brasília 6
Brescia 6
Denver 6
Dhaka 6
Guayaquil 6
Lima 6
London 6
Montreal 6
Quito 6
Venice 6
Yubileyny 6
Atlanta 5
Baghdad 5
Biên Hòa 5
Brussels 5
Campo Grande 5
Casablanca 5
Catania 5
Curitiba 5
Erbil 5
San Francisco 5
San Marzano di San Giuseppe 5
Stockholm 5
Totale 6.325
Salva come PNG Salva come JPEG
Nome #
M-VEC chemotherapy: new perspectives in the treatment of bladder cancer 189
Imperative indications for conservative surgery for renal cell carcinoma: 20 years' experience. 183
The role of lomefloxacin in the treatment of chronic prostatitis. 183
Localization of endothelin-converting enzyme-1 in human kidney 175
Computerized in vivo research from the growth of urease-producing bacteria in the presence of antibiotics combined with propionhydroxamic acid 164
A combination of chemotherapy with M-VEC (methotrexate, vinblastine, epirubicin, cisplatin) in the treatment of metastatic carcinoma of the bladder [POLICHEMIOTERAPIA CON M-VEC (METOTRESSATO, VINBLASTINA, EPIRUBICINA, CISPLATINO) NEL TRATTAMENTO DEI PAZIENTI CON CARCINOMA VESCICALE METASTATICO] 159
Apparato Urogenitale 153
Calcolosi urinaria 152
Alterazioni della minzione 150
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 149
Conservative surgery of renal cell carcinoma: a retrospective analysis of 25 years of experience 148
Complete androgen blockade as treatment for advanted prostate cancer: clinical response and side-effects 147
Anomalie di sviluppo 145
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 145
Apparato Urogenitale 143
A phase III study of recombinant leukocyte alpha Inteferon and Vinblastine in metastatic renal cell carcinoma. Preliminary report. 143
Alterazioni della minzione 142
Anomalie di sviluppo 141
Early diagnosis and monitoring of superficial transitional call carcinoma by microsatellite analysis on urine sediment 139
Ureteral intussusception by a fibroepithelial polyp. 139
URINARY SYMPTOMS, QUALITY OF LIFE AND SEXUAL FUNCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY BEFORE AND AFTER PROSTATECTOMY: A PROSPECTIVE STUDY 138
ADAPTIVE MORPHOLOGICAL CHANGES OF THE INTESTINAL MUCOSA IN ORTHOTOPIC ILEAL BLADDERS. SHORT-TERM AND LONG-TERM EVALUATION. 138
Antibacterial activity of succinyl-norfloxacin in urinary infections: a comparative study 138
Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. 135
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer 135
Calcolosi urinaria 134
Leiomyoma of the corona glans penis. 129
The psoas bladder Hitch procedure in ureter lesions [LA PSOAS BLADDER HITCH NELL LESIONI DELL'URETERE] 129
Benign prostate hypertrophy and sexual activity: evaluation of prostate symptoms (IPSS) and erectile function (IIEF). 129
Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. 128
Epidemiology and risk factors in urolithiasis 126
cisti e lesioni vascolari 126
P53 gene mutations in transitional cell bladder carcinoma. 125
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 123
The role of molecular biology in bladder and prostatic carcinoma 123
Pathophysiology of reno-ureteral colic 123
Surgical repair of extensive ureteral loss by renal autotransplantation 122
Ureterouterine fistula as a complication of cesarean section 120
Biology and paraneoplastic syndromes of renal carcinoma [BIOLOGIA E SINDROMI PARANEOPLASTICHE DEL CARCINOMA RENALE] 120
Long-term results of anterior and posterior urethroplasty with actuarial evaluation of the success rates 118
Cisti e lesioni vascolari 116
Surgical treatment of bilateral large seminal vesicle cysts associated with unilateral renoureteral agenesis 115
Giant stone in enterocystoplasty 113
Urethral carcinoma recurrence in ileal orthotopic neobladder:urethrectomy and conversion in a continent pouch with abdominal stoma 112
Patologia dell'apparato genitale maschile 110
The treatment of primary neoplasm of the ureter. A review of sixty cases [IL TRATTAMENTO DELLE NEOPLASIE PRIMITIVE DELL'URETERE: REVISIONE DI 60 CASI] 108
Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. 103
Traumi dell'apparato urogenitale 101
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections. 101
Morphologic evaluation of urinary stones in patients with recurrent stone formation [VALUTAZIONE MORFOLOGICA DEI CALCOLI URINARI NEI PAZIENTI ABITUALI FORMATORI DI CALCOLI] 101
Therapy of uncomplicated urogenital infections: Comparative study between norfloxacin, enoxacin and ofloxacin [TERAPIA DELLE INFEZIONI URO-GENITALI NON COMPLICATE: STUDIO COMPARATIVO APERTO FRA NORFLOXACINA, ENOXACINA ED OFLOXACINA] 100
Natural history of renal cell carcinoma 100
Conservative surgery of renal cell carcinoma: Evaluation of the prognostic factors 97
Infezioni delle vie urinarie 96
Incidental prostatic carcinoma after suprapubic prostatectomy: Clinical and pathological evaluation 95
Recurrent calcium nephrolithiasis: Variations in the structure and growth of urinary crystals [NEFROLITIASI CALCICA RECIDIVANTE: VARIAZIONI NELLA STRUTTURA E NELLA CRESCITA DEI CRISTALLI URINARI] 93
The role of interferons in the treatment of urinary tract cancer [IL RUOLO DEGLI INTERFERONI NEL TRATTAMENTO DELLE NEOPLASIE UROLOGICHE] 93
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections 92
Il trapianto renale nei pazienti a rischio 91
Lesioni ostruttive 91
Interferon alpha 2A in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study 90
Neo-adjuvant M-VEC chemotherapy in the treatment of bladder cancer: our experience on 12 patients 90
Tumori dell'apparato urinario 89
Patologia dell'apparto genitale maschile 88
Painless non invasive lithotripsy of pelvic and iuxtavesical ureteral stones 88
Somatomedin C in the seminal plasma of subjects with azoospermia 88
The role of fluoro-deoxyuridine (FUDR) in continuous circadian administration in the therapy of metastatic renal carcinoma: Our experience in 10 cases [IL RUOLO DELLA FLUORODESOSSIURIDINA (FUDR) IN SOMMINISTRAZIONE CIRCADIANA CONTINUA NELLA TERAPIA DEL CARCINOMA RENALE METASTATICO: NOSTRA ESPERIENZA SU 10 CASI] 87
Correlations between multiple rectal examination, PSA, transrectal echography and Gleason score in the screening of suspected prostatic carcinoma [CORRELAZIONI FRA ESPLORAZIONE RETTALE MULTIPLA, PSA, ECOGRAFIA TRANSRETTALE E GLEASON SCORE NELLO SCREENING DEL NODULO PROSTATICO SOSPETTO] 86
Intravesical antiblastic prophylaxis: Inteferon alpha . 4 epidoxorubicin versus 4 epidoxorubicin. Results of a randomized study [PROFILASSI ANTIBLASTICA ENDOVESCICALE: INTEFERONE ALFA + 4 EPIDOXORUBICINA VERSUS 4 EPIDOXORUBICINA. RISULTATI DI UNO STUDIO RANDOMIZZATO] 86
Interferon alpha 2 a and vinblastine in th treatment of metastatic renal carcinoma 86
Mepartricin in the treatment of benign prostatic diseases: Four years experience 85
Renal autotransplantation in reconstructive surgery of the ureter [L'AUTOTRAPIANTO RENALE NELLA CHIRURGIA RIPARATIVA DELL'URETERE] 85
Correlations between cytogenetic analysis and static cytometry in renal carcinoma [CORRELAZIONI FRA ANALISI CITOGENETICA E CITOMETRIA STATICA NEL CARCINOMA RENALE] 85
Intravesical immunotherapy with alpha 2A Interferon in patients with superficial bladder tumors. 84
Intravesical immunotherapy with alpha 2A Interferon in patients with superficial bladder tumors. 84
Intra-operative antibiotic perfusion in the renal artery in patients with infection induced staghorn calculi 84
Prostatectomia radicale retropubica nerve sparing: modifiche di tecnica 83
Leuprolide depot in treatment of advanced prostatic carcinoma: a dose related clinical and endocrinological evaluation. 81
Modulation of the role of androgens in the production of growth factor receptors in the prostatic tissue of men with prostate hyperplasia [MODULAZIONE DA PARTE DEGLI ANDROGENI DELLA PRODUZIONE DI RECETTORI PER I FATTORI DI ACCRESCIMENTO NEL TESSUTO PROSTATICO DI PROSTATE IPERPLASTICHE] 80
Tumori dell'apparato urinario 80
Traumi dell'apparato urogenitale 78
Lesioni ostruttive 78
Infezioni delle vie urinarie 77
Vascular disease, trauma and infections of the retroperitoneum (except retroperitoneal fibrosis) [PATOLOGIA VASCOLARE, TRAUMATICA E SINDROMI INFIAMMATORIE DEL RETROPERITONEO (ESCLUSA LA FIBROSIS RETROPERITONEALE)] 76
The role of recombinant Interferon alpha 2 A in endocavitary prophylaxis of superficial bladder tumors. 76
Frequently isolated uropathogenic strains and antibiotic resistance: An essential basis to a rational therapeutic approach in urinary tract infections [FREQUENZA DI ISOLAMENTO DEI GERMI UROPATOGENI ED ANTIBIOTICORESISTENZA: PREMESSE INDISPENSABILI AD UN APPROCCIO TERAPEUTICO RAZIONALE DELLE INFEZIONI URINARIE] 73
null 43
Totale 9.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022454 2 69 1 25 12 9 10 25 14 8 101 178
2022/20231.177 150 80 44 75 110 255 186 82 105 5 32 53
2023/2024350 14 60 92 29 15 36 6 52 3 11 15 17
2024/20253.725 120 327 203 430 1.407 611 44 224 145 57 85 72
2025/20262.866 291 442 230 160 304 91 408 116 184 126 62 452
2026/20276 6 0 0 0 0 0 0 0 0 0 0 0
Totale 9.886